{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:31:49Z","timestamp":1794493909197,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7800","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2020,3,26]]},"DOI":"10.1038\/s41586-020-2027-0","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T12:04:02Z","timestamp":1581336242000},"page":"609-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":297,"title":["Virtual discovery of melatonin receptor ligands to modulate circadian rhythms"],"prefix":"10.1038","volume":"579","author":[{"given":"Reed M.","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"McCorvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Glatfelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-3027","authenticated-orcid":false,"given":"Tao","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Savych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurii S.","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7626-2021","authenticated-orcid":false,"given":"Benjamin","family":"Stauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-5142","authenticated-orcid":false,"given":"Linda C.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-3914","authenticated-orcid":false,"given":"Vadim","family":"Cherezov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Kenakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-7367","authenticated-orcid":false,"given":"Brian K.","family":"Shoichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita L.","family":"Dubocovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"2027_CR1","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/bph.14116","volume":"175","author":"N Zisapel","year":"2018","unstructured":"Zisapel, N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br. J. Pharmacol. 175, 3190\u20133199 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"2027_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","volume":"62","author":"ML Dubocovich","year":"2010","unstructured":"Dubocovich, M. L. et al. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol. Rev. 62, 343\u2013380 (2010).","journal-title":"Pharmacol. Rev."},{"key":"2027_CR3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev-pharmtox-010814-124742","volume":"56","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu. Rev. Pharmacol. Toxicol. 56, 361\u2013383 (2016).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2027_CR4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.sleep.2007.10.007","volume":"8","author":"ML Dubocovich","year":"2007","unstructured":"Dubocovich, M. L. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. 8, 34\u201342 (2007).","journal-title":"Sleep Med."},{"key":"2027_CR5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/sleep\/28.10.1271","volume":"28","author":"K Mundey","year":"2005","unstructured":"Mundey, K., Benloucif, S., Harsanyi, K., Dubocovich, M. L. & Zee, P. C. Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep 28, 1271\u20131278 (2005).","journal-title":"Sleep"},{"key":"2027_CR6","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(08)61812-7","volume":"373","author":"SM Rajaratnam","year":"2009","unstructured":"Rajaratnam, S. M. et al. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet 373, 482\u2013491 (2009).","journal-title":"Lancet"},{"key":"2027_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31887\/DCNS.2007.9.3\/alewy","volume":"9","author":"AJ Lewy","year":"2007","unstructured":"Lewy, A. J. et al. The phase shift hypothesis for the circadian component of winter depression. Dialogues Clin. Neurosci. 9, 291\u2013300 (2007).","journal-title":"Dialogues Clin. Neurosci."},{"key":"2027_CR8","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1111\/bph.13536","volume":"173","author":"R Jockers","year":"2016","unstructured":"Jockers, R. et al. Update on melatonin receptors: IUPHAR Review 20. Br. J. Pharmacol. 173, 2702\u20132725 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"2027_CR9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","volume":"9","author":"C de Bodinat","year":"2010","unstructured":"de Bodinat, C. et al. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat. Rev. Drug Discov. 9, 628\u2013642 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2027_CR10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/jm0255872","volume":"46","author":"C Descamps-Fran\u00e7ois","year":"2003","unstructured":"Descamps-Fran\u00e7ois, C. et al. Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands. J. Med. Chem. 46, 1127\u20131129 (2003).","journal-title":"J. Med. Chem."},{"key":"2027_CR11","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.bmc.2011.06.063","volume":"19","author":"G Spadoni","year":"2011","unstructured":"Spadoni, G. et al. Bivalent ligand approach on N-2-[(3-methoxyphenyl)methylamino]ethylacetamide: synthesis, binding affinity and intrinsic activity for MT1 and MT2 melatonin receptors. Bioorg. Med. Chem. 19, 4910\u20134916 (2011).","journal-title":"Bioorg. Med. Chem."},{"key":"2027_CR12","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1039\/C5MD00190K","volume":"6","author":"DP Zlotos","year":"2015","unstructured":"Zlotos, D. P., Riad, N. M., Osman, M. B., Dodda, B. R. & Witt-Enderby, P. A. Novel difluoroacetamide analogues of agomelatine and melatonin: probing the melatonin receptors for MT1 selectivity. MedChemComm 6, 1340\u20131344 (2015).","journal-title":"MedChemComm"},{"key":"2027_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41586-019-1141-3","volume":"569","author":"B Stauch","year":"2019","unstructured":"Stauch, B. et al. Structural basis of ligand recognition at the human MT1 melatonin receptor. Nature 569, 284\u2013288 (2019).","journal-title":"Nature"},{"key":"2027_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-019-1144-0","volume":"569","author":"LC Johansson","year":"2019","unstructured":"Johansson, L. C. et al. XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity. Nature 569, 289\u2013292 (2019).","journal-title":"Nature"},{"key":"2027_CR15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","volume":"566","author":"J Lyu","year":"2019","unstructured":"Lyu, J. et al. Ultra-large library docking for discovering new chemotypes. Nature 566, 224\u2013229 (2019).","journal-title":"Nature"},{"key":"2027_CR16","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1021\/acs.jmedchem.8b00718","volume":"61","author":"DR Weiss","year":"2018","unstructured":"Weiss, D. R. et al. Selectivity challenges in docking screens for GPCR targets and antitargets. J. Med. Chem. 61, 6830\u20136845 (2018).","journal-title":"J. Med. Chem."},{"key":"2027_CR17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","volume":"537","author":"A Manglik","year":"2016","unstructured":"Manglik, A. et al. Structure-based discovery of opioid analgesics with reduced side effects. Nature 537, 185\u2013190 (2016).","journal-title":"Nature"},{"key":"2027_CR18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature15699","volume":"527","author":"XP Huang","year":"2015","unstructured":"Huang, X. P. et al. Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65. Nature 527, 477\u2013483 (2015).","journal-title":"Nature"},{"key":"2027_CR19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nchembio.2334","volume":"13","author":"K Lansu","year":"2017","unstructured":"Lansu, K. et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat. Chem. Biol. 13, 529\u2013536 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"2027_CR20","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15\u2014ligand discovery for everyone. J. Chem. Inf. Model. 55, 2324\u20132337 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"2027_CR21","doi-asserted-by":"crossref","first-page":"e75992","DOI":"10.1371\/journal.pone.0075992","volume":"8","author":"RG Coleman","year":"2013","unstructured":"Coleman, R. G., Carchia, M., Sterling, T., Irwin, J. J. & Shoichet, B. K. Ligand pose and orientational sampling in molecular docking. PLoS ONE 8, e75992 (2013).","journal-title":"PLoS ONE"},{"key":"2027_CR22","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento, A. P. et al. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 42, D1083\u2013D1090 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2027_CR23","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1021\/acs.jmedchem.5b02008","volume":"59","author":"JJ Irwin","year":"2016","unstructured":"Irwin, J. J. & Shoichet, B. K. Docking screens for novel ligands conferring new biology. J. Med. Chem. 59, 4103\u20134120 (2016).","journal-title":"J. Med. Chem."},{"key":"2027_CR24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/ci7004498","volume":"48","author":"SW Muchmore","year":"2008","unstructured":"Muchmore, S. W. et al. Application of belief theory to similarity data fusion for use in analog searching and lead hopping. J. Chem. Inf. Model. 48, 941\u2013948 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"2027_CR25","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1021\/jm901647p","volume":"53","author":"V Katritch","year":"2010","unstructured":"Katritch, V. et al. Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists. J. Med. Chem. 53, 1799\u20131809 (2010).","journal-title":"J. Med. Chem."},{"key":"2027_CR26","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1021\/jm2011589","volume":"54","author":"C de Graaf","year":"2011","unstructured":"de Graaf, C. et al. Crystal structure-based virtual screening for fragment-like ligands of the human histamine H1 receptor. J. Med. Chem. 54, 8195\u20138206 (2011).","journal-title":"J. Med. Chem."},{"key":"2027_CR27","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1021\/acschembio.7b00493","volume":"12","author":"B M\u00e4nnel","year":"2017","unstructured":"M\u00e4nnel, B. et al. Structure-guided screening for functionally selective D2 dopamine receptor ligands from a virtual chemical library. ACS Chem. Biol. 12, 2652\u20132661 (2017).","journal-title":"ACS Chem. Biol."},{"key":"2027_CR28","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1021\/jm7014777","volume":"51","author":"R Kiss","year":"2008","unstructured":"Kiss, R. et al. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening. J. Med. Chem. 51, 3145\u20133153 (2008).","journal-title":"J. Med. Chem."},{"key":"2027_CR29","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1021\/jm201376w","volume":"55","author":"M Congreve","year":"2012","unstructured":"Congreve, M. et al. Discovery of 1,2,4-triazine derivatives as adenosine A2A antagonists using structure based drug design. J. Med. Chem. 55, 1898\u20131903 (2012).","journal-title":"J. Med. Chem."},{"key":"2027_CR30","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1021\/jm201455y","volume":"55","author":"CJ Langmead","year":"2012","unstructured":"Langmead, C. J. et al. Identification of novel adenosine A2A receptor antagonists by virtual screening. J. Med. Chem. 55, 1904\u20131909 (2012).","journal-title":"J. Med. Chem."},{"key":"2027_CR31","first-page":"1042.5","volume":"26","author":"EB Adamah-Biassi","year":"2012","unstructured":"Adamah-Biassi, E. B., Stepien, I., Hudson, R. L. & Dubocovich, M. L. Effects of the melatonin receptor antagonist (MT2)\/inverse agonist (MT1) luzindole on re-entrainment of wheel running activity and spontaneous homecage behaviors in C3H\/HeN Mice. FASEB J. 26, 1042.5 (2012).","journal-title":"FASEB J."},{"key":"2027_CR32","first-page":"902","volume":"246","author":"ML Dubocovich","year":"1988","unstructured":"Dubocovich, M. L. Luzindole (N-0774): a novel melatonin receptor antagonist. J. Pharmacol. Exp. Ther. 246, 902\u2013910 (1988).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2027_CR33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjp.0703130","volume":"129","author":"C Browning","year":"2000","unstructured":"Browning, C., Beresford, I., Fraser, N. & Giles, H. Pharmacological characterization of human recombinant melatonin mt1 and MT2 receptors. Br. J. Pharmacol. 129, 877\u2013886 (2000).","journal-title":"Br. J. Pharmacol."},{"key":"2027_CR34","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1096\/fasebj.12.12.1211","volume":"12","author":"ML Dubocovich","year":"1998","unstructured":"Dubocovich, M. L., Yun, K., Al-Ghoul, W. M., Benloucif, S. & Masana, M. I. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J. 12, 1211\u20131220 (1998).","journal-title":"FASEB J."},{"key":"2027_CR35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/074873049601100204","volume":"11","author":"S Benloucif","year":"1996","unstructured":"Benloucif, S. & Dubocovich, M. L. Melatonin and light induce phase shifts of circadian activity rhythms in the C3H\/HeN mouse. J. Biol. Rhythms 11, 113\u2013125 (1996).","journal-title":"J. Biol. Rhythms"},{"key":"2027_CR36","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/jc.2009-2590","volume":"95","author":"HJ Burgess","year":"2010","unstructured":"Burgess, H. J., Revell, V. L., Molina, T. A. & Eastman, C. I. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg. J. Clin. Endocrinol. Metab. 95, 3325\u20133331 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2027_CR37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/07420528.2010.532894","volume":"28","author":"O Rawashdeh","year":"2011","unstructured":"Rawashdeh, O., Hudson, R. L., Stepien, I. & Dubocovich, M. L. Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H\/HeN mice. Chronobiol. Int. 28, 31\u201338 (2011).","journal-title":"Chronobiol. Int."},{"key":"2027_CR38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(97)00382-X","volume":"762","author":"O Van Reeth","year":"1997","unstructured":"Van Reeth, O. et al. Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters. Brain Res. 762, 185\u2013194 (1997).","journal-title":"Brain Res."},{"key":"2027_CR39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-2999(02)01407-3","volume":"439","author":"C Er\u015fahin","year":"2002","unstructured":"Er\u015fahin, C., Masana, M. I. & Dubocovich, M. L. Constitutively active melatonin MT1 receptors in male rat caudal arteries. Eur. J. Pharmacol. 439, 171\u2013172 (2002).","journal-title":"Eur. J. Pharmacol."},{"key":"2027_CR40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/jpet.103.049916","volume":"306","author":"JM Soares Jr","year":"2003","unstructured":"Soares, J. M. Jr, Masana, M. I., Er\u015fahin, C. & Dubocovich, M. L. Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J. Pharmacol. Exp. Ther. 306, 694\u2013702 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2027_CR41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/07420529808998671","volume":"15","author":"AJ Lewy","year":"1998","unstructured":"Lewy, A. J. et al. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol. Int. 15, 71\u201383 (1998).","journal-title":"Chronobiol. Int."},{"key":"2027_CR42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00441-002-0576-1","volume":"309","author":"MU Gillette","year":"2002","unstructured":"Gillette, M. U. & Mitchell, J. W. Signaling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res. 309, 99\u2013107 (2002)","journal-title":"Cell Tissue Res."},{"key":"2027_CR43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archneur.58.7.1089","volume":"58","author":"KJ Reid","year":"2001","unstructured":"Reid, K. J. et al. Familial advanced sleep phase syndrome. Arch. Neurol. 58, 1089\u20131094 (2001).","journal-title":"Arch. Neurol."},{"key":"2027_CR44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-biophys-051013-022942","volume":"46","author":"I Kufareva","year":"2017","unstructured":"Kufareva, I., Gustavsson, M., Zheng, Y., Stephens, B. S. & Handel, T. M. What do structures tell us about chemokine receptor function and antagonism? Annu. Rev. Biophys. 46, 175\u2013198 (2017).","journal-title":"Annu. Rev. Biophys."},{"key":"2027_CR45","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.drudis.2015.08.003","volume":"20","author":"RM Cooke","year":"2015","unstructured":"Cooke, R. M., Brown, A. J., Marshall, F. H. & Mason, J. S. Structures of G protein-coupled receptors reveal new opportunities for drug discovery. Drug Discov. Today 20, 1355\u20131364 (2015).","journal-title":"Drug Discov. Today"},{"key":"2027_CR46","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1016\/S0021-9258(17)33257-X","volume":"251","author":"RJ Lefkowitz","year":"1976","unstructured":"Lefkowitz, R. J., Mullikin, D. & Caron, M. G. Regulation of \u03b2-adrenergic receptors by guanyl-5\u2032-yl imidodiphosphate and other purine nucleotides. J. Biol. Chem. 251, 4686\u20134692 (1976).","journal-title":"J. Biol. Chem."},{"key":"2027_CR47","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1006\/jmbi.1998.2401","volume":"285","author":"JM Word","year":"1999","unstructured":"Word, J. M., Lovell, S. C., Richardson, J. S. & Richardson, D. C. Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 285, 1735\u20131747 (1999).","journal-title":"J. Mol. Biol."},{"key":"2027_CR48","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/ja00315a051","volume":"106","author":"SJ Weiner","year":"1984","unstructured":"Weiner, S. J. et al. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 106, 765\u2013784 (1984).","journal-title":"J. Am. Chem. Soc."},{"key":"2027_CR49","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1021\/jm100240h","volume":"53","author":"J Carlsson","year":"2010","unstructured":"Carlsson, J. et al. Structure-based discovery of A2A adenosine receptor ligands. J. Med. Chem. 53, 3748\u20133755 (2010).","journal-title":"J. Med. Chem."},{"key":"2027_CR50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0006-3495(98)77566-6","volume":"75","author":"K Gallagher","year":"1998","unstructured":"Gallagher, K. & Sharp, K. Electrostatic contributions to heat capacity changes of DNA-ligand binding. Biophys. J. 75, 769\u2013776 (1998).","journal-title":"Biophys. J."},{"key":"2027_CR51","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/ci100214a","volume":"50","author":"MM Mysinger","year":"2010","unstructured":"Mysinger, M. M. & Shoichet, B. K. Rapid context-dependent ligand desolvation in molecular docking. J. Chem. Inf. Model. 50, 1561\u20131573 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"2027_CR52","doi-asserted-by":"crossref","first-page":"D1054","DOI":"10.1093\/nar\/gkv1037","volume":"44","author":"C Southan","year":"2016","unstructured":"Southan, C. et al. The IUPHAR\/BPS guide to pharmacology in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res. 44, D1054\u2013D1068 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2027_CR53","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acscombsci.6b00103","volume":"18","author":"A Tolmachev","year":"2016","unstructured":"Tolmachev, A. et al. Expanding synthesizable space of disubstituted 1,2,4-oxadiazoles. ACS Comb. Sci. 18, 616\u2013624 (2016).","journal-title":"ACS Comb. Sci."},{"key":"2027_CR54","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nsmb.3014","volume":"22","author":"WK Kroeze","year":"2015","unstructured":"Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome. Nat. Struct. Mol. Biol. 22, 362\u2013369 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"2027_CR55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","volume":"3","author":"T Kenakin","year":"2012","unstructured":"Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A. & Novick, S. A simple method for quantifying functional selectivity and agonist bias. ACS Chem. Neurosci. 3, 193\u2013203 (2012).","journal-title":"ACS Chem. Neurosci."},{"key":"2027_CR56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/pr.118.016790","volume":"71","author":"T Kenakin","year":"2019","unstructured":"Kenakin, T. Biased receptor signaling in drug discovery. Pharmacol. Rev. 71, 267\u2013315 (2019).","journal-title":"Pharmacol. Rev."},{"key":"2027_CR57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-418687-3.00018-5","volume":"529","author":"PA Longo","year":"2013","unstructured":"Longo, P. A., Kavran, J. M., Kim, M. S. & Leahy, D. J. Transient mammalian cell transfection with polyethylenimine (PEI). Methods Enzymol. 529, 227\u2013240 (2013).","journal-title":"Methods Enzymol."},{"key":"2027_CR58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","volume":"492","author":"J Besnard","year":"2012","unstructured":"Besnard, J. et al. Automated design of ligands to polypharmacological profiles. Nature 492, 215\u2013220 (2012).","journal-title":"Nature"},{"key":"2027_CR59","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/acs.chemrestox.6b00301","volume":"30","author":"M Popovska-Gorevski","year":"2017","unstructured":"Popovska-Gorevski, M., Dubocovich, M. L. & Rajnarayanan, R. V. Carbamate insecticides target human melatonin receptors. Chem. Res. Toxicol. 30, 574\u2013582 (2017).","journal-title":"Chem. Res. Toxicol."},{"key":"2027_CR60","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"Y-C Cheng","year":"1973","unstructured":"Cheng, Y.-C. & Prusoff, W. H. Relationship between the inhibition constant (K\nI) and the concentration of inhibitor which causes 50 per cent inhibition (I\n50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099\u20133108 (1973).","journal-title":"Biochem. Pharmacol."},{"key":"2027_CR61","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1600-079X.2005.00233.x","volume":"39","author":"IC Sumaya","year":"2005","unstructured":"Sumaya, I. C., Masana, M. I. & Dubocovich, M. L. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. J. Pineal Res. 39, 170\u2013177 (2005).","journal-title":"J. Pineal Res."},{"key":"2027_CR62","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-079X.2005.00230.x","volume":"39","author":"ML Dubocovich","year":"2005","unstructured":"Dubocovich, M. L., Hudson, R. L., Sumaya, I. C., Masana, M. I. & Manna, E. Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL\/6 mouse. J. Pineal Res. 39, 113\u2013120 (2005).","journal-title":"J. Pineal Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-2027-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-2027-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-020-2027-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:03:10Z","timestamp":1684605790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-020-2027-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":62,"journal-issue":{"issue":"7800","published-print":{"date-parts":[[2020,3,26]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1038\/s41586-020-2027-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737342707.793571433","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"3 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.K.S. and J.J.I. are founders of a company, BlueDolphin LLC, that works in the area of molecular docking. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}